top of page
Boustead IPO Client Blue Water Vaccines ("BWV") Announces Closing of Initial Public Offering
Irvine, CA, & Cincinnati, OH — February 23, 2022 – Boustead Securities, LLC (“Boustead”) IPO client Blue Water Vaccines Inc. ("BWV" or...
Boustead IPO Client HeartCore Enterprises, Inc. Announces Closing of $15.0 Million Nasdaq IPO
Irvine, CA, Tokyo, and New York, NY — February 14, 2022 – Boustead Securities, LLC (“Boustead”) IPO client HeartCore Enterprises, Inc.,...
Boustead Client HeartCore Enterprises, Inc. ("HTCR") Announces Pricing of $15.0 Million IPO
Irvine, CA, Tokyo, and New York, NY — February 9, 2022 – Boustead Securities, LLC (“Boustead”) IPO client HeartCore Enterprises, Inc.,...
Boustead Client Newt Signs Agreement with Element Bank for its Digital Lending Program in Mexico
Irvine, CA and Toronto, Ontario — February 2, 2021 – Boustead Securities, LLC (“Boustead”) client Newt Corporation (“Newt”or the...
Cytta (CYCA) Engages Boustead Securities as Exclusive Financial Advisor
Las Vegas, NV & Irvine, CA – January 28, 2022 – Boustead Securities, LLC (“Boustead”) client Cytta Corp (OTCQB: CYCA, the “Company”) is...
bottom of page